What is Barclays's price target for BHG?

Barclays's latest stated price target for Bright Health Group Inc. (BHG) is $4, from its action on Mar 3, 2022.

What is Barclays's rating on BHG?

Barclays rates BHG Overweight, a bullish rating, as of Mar 3, 2022.

When did Barclays last change its view on BHG?

On Mar 3, 2022, Barclays cuts its price target to $4 from $5.50, keeps Overweight.

Barclays BHG price target and rating history

Bright Health Group Inc. (BHG) · Health Care

Barclays rates Bright Health Group Inc. (BHG) Overweight with a $4 price target, as of its latest action on Mar 3, 2022. It has published 3 rating actions on BHG since November 2021, including 0 upgrades and 0 downgrades.

Current rating: Overweight
Price target: $4
Median target, all firms: Too few
Actions on BHG: 3

Barclays price target on BHG

Barclays price target on BHG, each point a stated target, November 2021 to March 2022.

Every Barclays rating on BHG

Mar 3, 2022
ReiterateBarclays cuts its price target to $4 from $5.50, keeps Overweight
Jan 7, 2022
ReiterateBarclays cuts its price target to $5.50 from $9, keeps Overweight
Nov 10, 2021
ReiterateBarclays cuts its price target to $12 from $17, keeps Overweight

Questions about Barclays and BHG

What is Barclays's price target for BHG?: Barclays's latest stated price target for Bright Health Group Inc. (BHG) is $4, from its action on Mar 3, 2022.
What is Barclays's rating on BHG?: Barclays rates BHG Overweight, a bullish rating, as of Mar 3, 2022.
When did Barclays last change its view on BHG?: On Mar 3, 2022, Barclays cuts its price target to $4 from $5.50, keeps Overweight.

More BHG rating histories

All Barclays ratings BHG news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.